Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients

References

• Faulkner KG. Improving femoral bone density measurements. J Clinic Densitom 2003;6:353–8.
   PubMed Web of Science ®Google Scholar
• Liu EY, Wactawski-Wende J, Donahue RP, Dmochowski J, Hovey KM, Quattrin T. Does low bone mineral density start in post-teenage years in women with type 1 diabetes? Diabetes Care 2003;26:2365–9.
   PubMed Web of Science ®Google Scholar
• Miazgowski T, Pynka S, Noworyta-Zietara M, Krzyzanowska-Swiniarska B, Pikul R. Bone mineral density and hip structural analysis in type 1 diabetic men. Eur J Endocrinol 2007;156:123–7.
   PubMed Web of Science ®Google Scholar
• Zebrowska A, Waszczykowska E. Osteopenia and osteoporosis in patients with dermatitis herpetifomis free diet. Arch Med Sci 2007;3:252–6.
   Web of Science ®Google Scholar
• Rosen JF. The epidemiology and pathogenesis of osteoporosis. endotext.com. Chapter 11, 2004.
   Google Scholar
• Tanner JM, Whitehouse RH. A note on the bone age at which patients with true isolated growth hormone deficiency enter puberty. J Clin Endocrinol Metab 1975;41:788–90.
   PubMed Web of Science ®Google Scholar
• Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. Arch Dis Child 1966;4:613–35.
   Google Scholar
• Warner JT, Cowan FJ, Dunstan FDJ, Evans FD, Webb DKH, Gregory JW. Measured and predicted bone mineral content in healthy boys and girls aged 6–18 years: adjustment for body size and puberty. Acta Paediatr 1998;87: 244–9.
   PubMed Web of Science ®Google Scholar
• Brandaoa FR, Vicentec EJ, Daltroa CH, Sacramentob M, Moreirad A and Adana L. Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus. Diabetes Res Clin Prac 2007;78:334–9.
   PubMed Web of Science ®Google Scholar
• World Health Organization study group. Assessment of fracture risk, and its application to screening for postmenopausal osteoporosis. World Health Organization Technical Reports Series, No 843.Geneva, 1994.
   Google Scholar
• Alexopoulou O, Jamart J, Devogelaef JP, Brichardl S, de Nayer P, Buysschaert M. Bone density and markers of bone remodeling in type 1 male diabetic patients. Diabetes Metab 2006;32:453–8.
   PubMed Web of Science ®Google Scholar
• Ahlborg HG, Nguyen ND, Nguyen TV, Center JR, Eisman JA. Contribution of hip strength indices to hip fracture risk in elderly men and women. J Bone Min Res 2005;10: 1820–7.
   Google Scholar
• Bechtold S, Dirlenbach I, Raile K, Noelle V, Bonfig W, Schwarz HP. Early manifestation of type 1 diabetes in children is a risk factor for changed bone geometry: Data using peripheral quantitative computed tomography. Pediatrics 2006;118:e627–34.
   PubMed Web of Science ®Google Scholar
• Moyer-Mileur LJ, Dixon SB, Quick JL, Askew EW, Murray MA. Bone mineral acquisition in adolescents with type 1 diabetes. J Pediatr 2004;145:662–9.
   PubMed Web of Science ®Google Scholar
• Rakel A, Sheehy O, Rahme E, Lelorier J. Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab 2008;34:193–205.
   PubMed Web of Science ®Google Scholar
• Bonfanti R, Mora S, Prinster C, Bognetti E, Meschi F, Puzzovio M, Proverbio MC, Chiumello G. Bone modeling indexes at onset and during the first year of follow-up in insulin-dependent diabetic children. Calcif Tissue Int 1997;60:397–400.
   PubMed Web of Science ®Google Scholar
• McCarthy AD, Uemura T, Etcheverry SB, Cortizo AM. Advanced glycation end products interfere with integrin-mediated osteoblastic attachment to type-I collagen matrix. Int J Biochem cell Biol 2004;36:840–8.
   PubMed Web of Science ®Google Scholar
• McCabe LR, Botolin S. Osmoadaptation impairs osteoblast differentiation. J Bone Min Res 2003;18:S229.
   Web of Science ®Google Scholar
• Thrailkill KM. Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects and potential clinical utility. Diabetes Technol Ther 2000;2:69–80.
   PubMedGoogle Scholar
• Thrailkill KM, Lumpkin CK, Clay Bunn JR, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 2005;289:E735–45.
   PubMed Web of Science ®Google Scholar
• Bachrach L. Acquisition of optimal bone mass in children and adolescent. Trends Endocrinol Metab 2001; 12:22–28.
   PubMed Web of Science ®Google Scholar
• Munoz Torres M, Jodar E, Escobar-Jimenez F, Lopez-Ibarra PJ, Luna JD. Bone mineral density measured by dual x-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus. Calcif Tissue Int 1996;58:316–9.
   PubMed Web of Science ®Google Scholar
• Rosen H. Bone physiology and biochemical markers of bone turnover. Up To Date, 2004.
   Google Scholar
• Suzuki K, Kurose T, Takizawa M, Maruyama M, Ushikawa K, Kikuyama M, Sugimoto C, Seino Y, Nagamatsu S, Ishida H. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteopeoprotegerin (OCIF/ OPG) on the decrease of bone mineral density. Diabetes Res Clin Pract 2005;68:117–25.
   PubMed Web of Science ®Google Scholar
• Szulc P, Hofbauer LC, Heufelder AE. Roth S. Delmas PD. Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 2001;86:3162–5.
   PubMed Web of Science ®Google Scholar
• Bridges MJ, Moochhala SH, Barbour J, Kelly CA. Influence of diabetes on peripheral bone mineral density in men: a controlled study. Acta Diabetologica 2005;42:82–6.
   PubMed Web of Science ®Google Scholar
• Gunczler P, Lanes R, Paoli M, Martinez V, Villarel O, Weisinger JR. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2001;14: 525–8.
   PubMed Web of Science ®Google Scholar
• Salvatoni A, Mancassola G, Biasoli R, Cardani R, Salvatore S, Broggini M, Nespoli L. Bone mineral density in diabetic children and adolescents: a follow-up study. Bone 2004; 34:900–4.
   PubMed Web of Science ®Google Scholar
• McNair P, Christiansen C, Christensen MS, Madsbad S, Faber OK, Binder C, Transbøl I. Development of bone mineral loss in insulin-treated diabetes: a 1½ years follow up study in sixty patients. Eur J Clin Invest 1981;11:55–9.
   PubMed Web of Science ®Google Scholar
• Léger J, Marinovic D, Alberti C, Dorgeret S, Chevenne D, Lévy Marchal C, Tubiana-Rufi N, Sebag G, Czernichow P. Lower bone mineral content in children with type 1 diabetes mellitus is linked to female sex, low insulin-like growth factor type I levels, and high insulin requirement. J Clin Endocrinol Metab 2006;91:3947–53.
   PubMed Web of Science ®Google Scholar
• Valerio G, del Puente A, Esposito-del Puente A, Buono P, Mozillo E, Franzese A. The lumbar bone mineral density is affected by long term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res 2002;58:266–72.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 2006;29:S4–42.
   PubMed Web of Science ®Google Scholar
• Dubé MC, Prud'homme D, Lemieux S, Lavoie C, Weisnagel SJ. Body composition indices in women with well-controlled type 1 diabetes. Diabetes Care 2008;31:e48.
   PubMedGoogle Scholar
• Kabadi UM, Vora A, Kabadi M. Hyperinsulinemia and central adiposity: influence of chronic insulin therapy in type 1 diabetes. Diabetes Care 2000;23:1024–5.
   PubMed Web of Science ®Google Scholar
• Ingberg CM, Sarnblad S, Palmer M, Schvarcz E, Berne C, Aman J. Body composition in adolescent girls with type 1 diabetes. Diabetes Med 2003;20:1005–11.
   PubMed Web of Science ®Google Scholar
• Svendsen OL, Hassager C. Body composition and fat distribution measured by Dual-Energy x-ray absorptiometry in premenopausal and postmenopausal insulin dependent and non insulin dependent diabetes mellitus patients. Metabolism 1998;47:212–6.
   PubMed Web of Science ®Google Scholar
• Compston JE, Smith EM, Mathews C, Schofield P. Whole body composition and regional bone mass in women with insulin-dependent diabetes mellitus. Clin Endocrinol 1994; 41:289–93.
   PubMed Web of Science ®Google Scholar
• Rosenfalck AM, Snorgaad O, Almdal T, Binder C. Creatinine height index and lean body mass in adult patients with insulin-dependent diabetes mellitus followed for 7 years from onset. J Parenter Enteral Nutr 1994;18:50–4.
   PubMed Web of Science ®Google Scholar